BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng G, Servaes S, Zhuang H. Value of 18 F-fluoro-2-deoxy- d -glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma. Leukemia & Lymphoma 2012;54:737-42. [DOI: 10.3109/10428194.2012.727416] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Saade-Lemus S, Nevo E, Soliman I, Otero HJ, Magee RW, Drum ET, States LJ. Clinical pediatric positron emission tomography/magnetic resonance program: a guide to successful implementation. Pediatr Radiol 2020;50:607-17. [PMID: 32076750 DOI: 10.1007/s00247-019-04578-z] [Reference Citation Analysis]
2 Liu B, Chan S, Servaes S, Zhuang H. Multiple FDG-Avid Injection Site Granulomas Due to Lovenox Injection. Clinical Nuclear Medicine 2014;39:308-11. [DOI: 10.1097/rlu.0000000000000353] [Cited by in Crossref: 14] [Article Influence: 1.8] [Reference Citation Analysis]
3 Sanli Y, Yilmaz E, Subramaniam RM. Precision Medicine and PET-Computed Tomography in Pediatric Malignancies. PET Clin 2017;12:423-35. [PMID: 28867113 DOI: 10.1016/j.cpet.2017.05.009] [Reference Citation Analysis]
4 Jorgov L, Montravers F, Balogova S, Ragu C, Pacquement H, Leblanc T, Abbou S, Ducou-lepointe H, Landman-parker J, Talbot J. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT. Eur J Nucl Med Mol Imaging 2016;43:1220-30. [DOI: 10.1007/s00259-015-3280-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
5 Zheng W, Chen Y, Huang Z, Cai L. Burkitt Lymphoma Presented as Acute Lower Back Pain and Revealed by 18F-NaF PET/CT. Clinical Nuclear Medicine 2016;41:e253-4. [DOI: 10.1097/rlu.0000000000001109] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
6 Hassan A, Siddique M, Bashir H, Riaz S, Wali R, Mahreen A, Nawaz MK. 18F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin's lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement. Eur J Nucl Med Mol Imaging 2017;44:1198-206. [PMID: 28229191 DOI: 10.1007/s00259-017-3647-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
7 Bai X, Wang X, Zhuang H. Long-Lasting FDG Uptake in the Muscles After Strenuous Exercise. Clinical Nuclear Medicine 2015;40:975-6. [DOI: 10.1097/rlu.0000000000000958] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
8 Edwards KW. Preparation and Logistic Considerations in Performing PET and PET/Computed Tomography in Pediatric Patients. PET Clin 2020;15:285-92. [PMID: 32498984 DOI: 10.1016/j.cpet.2020.03.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zanoni L, Mattana F, Calabrò D, Paccagnella A, Broccoli A, Nanni C, Fanti S. Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma. Eur J Radiol 2021;141:109793. [PMID: 34148014 DOI: 10.1016/j.ejrad.2021.109793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ponisio MR, McConathy J, Laforest R, Khanna G. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Pediatr Radiol 2016;46:1258-68. [PMID: 27003132 DOI: 10.1007/s00247-016-3601-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
11 Sepehrizadeh T, Jong I, DeVeer M, Malhotra A. PET/MRI in paediatric disease. Eur J Radiol 2021;144:109987. [PMID: 34649143 DOI: 10.1016/j.ejrad.2021.109987] [Reference Citation Analysis]
12 Isik EG, Kuyumcu S, Kebudi R, Sanli Y, Karakas Z, Cakir FB, Unal SN. Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET/CT according to ΔSUVmax, Deauville 5-point scale and IHP criteria. Ann Nucl Med 2017;31:660-8. [DOI: 10.1007/s12149-017-1196-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
13 Allen CE, Kelly KM, Bollard CM. Pediatric lymphomas and histiocytic disorders of childhood. Pediatr Clin North Am 2015;62:139-65. [PMID: 25435117 DOI: 10.1016/j.pcl.2014.09.010] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
14 Muehe AM, Theruvath AJ, Lai L, Aghighi M, Quon A, Holdsworth SJ, Wang J, Luna-Fineman S, Marina N, Advani R, Rosenberg J, Daldrup-Link HE. How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach. Mol Imaging Biol 2018;20:324-35. [PMID: 28721605 DOI: 10.1007/s11307-017-1105-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
15 Niu N, Chen L, Liu Y, Li F. Multiple organ metastases from ameloblastoma detected by FDG PET/CT imaging. Clin Nucl Med 2013;38:1009-11. [PMID: 24152624 DOI: 10.1097/RLU.0b013e3182a7597f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
16 Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, Malhotra A, Dhawan D, Vishnubhatla S. Posttreatment PET/CT Rather Than Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET/CT with Conventional Imaging. J Nucl Med 2017;58:577-83. [PMID: 27754902 DOI: 10.2967/jnumed.116.176511] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
17 Kiratli PÖ, Tuncel M, Bar-Sever Z. Nuclear Medicine in Pediatric and Adolescent Tumors. Semin Nucl Med 2016;46:308-23. [PMID: 27237441 DOI: 10.1053/j.semnuclmed.2016.01.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
18 Kalisz K, Alessandrino F, Beck R, Smith D, Kikano E, Ramaiya NH, Tirumani SH. An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence. Insights Imaging 2019;10:56. [PMID: 31115699 DOI: 10.1186/s13244-019-0733-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
19 Bai X, Wang X. Solitary Benign Schwannoma Mimics Residual Malignancy on FDG PET/CT. Clin Nucl Med 2018;43:782-4. [PMID: 30153146 DOI: 10.1097/RLU.0000000000002245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Uslu L, Donig J, Link M, Rosenberg J, Quon A, Daldrup-Link HE. Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies. J Nucl Med 2015;56:274-86. [PMID: 25572088 DOI: 10.2967/jnumed.114.146290] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 8.9] [Reference Citation Analysis]
21 Teixeira SR, Martinez-Rios C, Hu L, Bangert BA. Clinical applications of pediatric positron emission tomography-magnetic resonance imaging. Semin Roentgenol 2014;49:353-66. [PMID: 25498232 DOI: 10.1053/j.ro.2014.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
22 Wen Z, Zhuang H. Acral Involvement of Lymphoblastic Lymphoma Revealed on FDG PET/CT. Clin Nucl Med 2019;44:334-6. [DOI: 10.1097/rlu.0000000000002470] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
23 Bıçakçı N, Elli M. 18Fluorine-fluorodeoxyglucose PET/CT Imaging in Childhood Malignancies. Mol Imaging Radionucl Ther 2021;30:18-27. [PMID: 33586403 DOI: 10.4274/mirt.galenos.2020.64436] [Reference Citation Analysis]
24 Kriel M, Davidson A, Pillay K, Hendricks M, Phillips LA. Clinicopathologic Characterization of Children With B-Cell Non-Hodgkin Lymphoma Over 10 Years at a Tertiary Center in Cape Town, South Africa. J Pediatr Hematol Oncol 2020;42:e219-27. [PMID: 32332383 DOI: 10.1097/MPH.0000000000001709] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Lin Y, Pan YH, Li MK, Zong XD, Pan XM, Tan SY, Guo YW. Clinical presentation of gastric Burkitt lymphoma presenting with paraplegia and acute pancreatitis: A case report. World J Gastroenterol 2021; 27(45): 7844-7854 [PMID: 34963746 DOI: 10.3748/wjg.v27.i45.7844] [Reference Citation Analysis]
26 Liu B, Lee NJ, Otero HJ, Servaes S, Zhuang H. Rosai-Dorfman Disease Mimics Lymphoma on FDG PET/CT in a Pediatric Patient. Clinical Nuclear Medicine 2014;39:206-8. [DOI: 10.1097/rlu.0000000000000267] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Liu Z, Yang X, Liu J, Yang J. FDG PET/CT Demonstrated Precursor B-cell Lymphoblastic Lymphoma in a Pediatric Patient With Hemophilia B. Clin Nucl Med 2019;44:683-5. [PMID: 31274624 DOI: 10.1097/RLU.0000000000002582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Cistaro A, Cassalia L, Ferrara C, Quartuccio N, Evangelista L, Bianchi M, Fagioli F, Bisi G, Baldari S, Zanella A, Pillon M, Zucchetta P, Burei M, Sala A, Guerra L, Guglielmo P, Burnelli R, Panareo S, Scalorbi F, Rambaldi I, Piccardo A, Garaventa A, Familiari D, Fornito MC, Lopci E, Mascarin M, Altini C, Ferrari C, Perillo T, Santoro N, Borsatti E, Rubini G. Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk 2018;18:e267-73. [PMID: 29739722 DOI: 10.1016/j.clml.2018.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]